z-logo
open-access-imgOpen Access
Depression Symptoms and Antidepressant Medicine Use in Diabetes Prevention Program Participants
Author(s) -
Richard R. Rubin,
William C. Knowler,
Yong Ma,
David G. Marrero,
Sharon L. Edelstein,
Elizabeth A. Walker,
Sanford Garfield,
Edwin B. Fisher
Publication year - 2005
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/diacare.28.4.830
Subject(s) - medicine , depression (economics) , antidepressant , placebo , beck depression inventory , diabetes mellitus , psychiatry , physical therapy , alternative medicine , endocrinology , anxiety , economics , macroeconomics , pathology , hippocampus
To assess depression markers (symptoms and antidepressant medicine use) in Diabetes Prevention Program (DPP) participants and to determine whether changes in depression markers during the course of the study were associated with treatment arm, weight change, physical activity level, or participant demographic characteristics.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom